Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Health 160 (02656.HK) AI hospital contract signings surge by 720%, OpenClaw's first commercialized stock launch triggers a new high in stock price!
Recently, China’s leading digital healthcare service platform, Healthy 160 (02656.HK), released a voluntary announcement revealing significant progress in the operation of its “160 AI Hospitals” partnership in 2025. The announcement states that in 2025, the company will have established operational partnerships with 82 public secondary and above hospitals under the “160 AI Hospitals” initiative, representing a year-over-year increase of over 720%. Notably, 52 new collaborations were completed in the fourth quarter of 2025, achieving a 420% quarter-over-quarter growth, indicating an accelerating pace of business expansion.
AI-empowered Hospital Operations, Building a Core Growth Engine
“160 AI Hospitals” is an integrated AI hospital solution launched by Healthy 160, aimed at deeply empowering hospital management through artificial intelligence technology. The solution covers the entire process before, during, and after diagnosis, integrating intelligent applications such as AI-guided consultation, AI appointment registration, AI pre-diagnosis, AI陪诊, AI medical assistance, and AI follow-up, dedicated to helping hospitals improve operational efficiency, enhance patient experience, and increase revenue.
The rapid growth of partner hospitals marks a shift for Healthy 160’s AI strategy from technological reserves and pilot phases toward large-scale commercial implementation. Collaborations with public secondary and above hospitals not only validate the applicability of their solutions in serious medical settings but also open up a more paying-capable and stable B2B market space for the company.
Strengthening Platform Ecosystem and Realizing Network Effects
Healthy 160’s core competitiveness lies in its extensive medical resource network accumulated over nearly two decades. As of June 30, 2025, the platform connected over 44,800 healthcare institutions, including more than 14,500 hospitals (including 3,441 tertiary hospitals), and collaborated with over 904,500 medical staff. The rapid advancement of the AI hospital partnership project is a key step in transforming this vast “connection” advantage into deep “operation” value.
By embedding AI solutions deeply into the daily operations of partner hospitals, Healthy 160 can further consolidate relationships with medical institutions, upgrading from mere traffic flow or system services to strategic partnerships that co-create value. This deep integration helps increase customer stickiness and lays the foundation for future diversified profit models based on operational performance sharing.
Improving Revenue Structure and Supporting Profitability Expectations
From a financial perspective, digital healthcare solutions are a high-margin business segment for Healthy 160. In the first half of 2025, this segment generated approximately RMB 793 million in revenue. The large-scale implementation of AI hospital operations is expected to accelerate growth in this high-margin business, optimizing the company’s overall revenue structure and enhancing profitability.
Several brokerages have recently pointed out in their research reports that Healthy 160 is entering a clear performance inflection point. Huasheng Securities, in a February 2026 report, noted that its AI-driven hospital operation upgrade solutions have helped a hospital in Shenzhen achieve annual revenue increases of over RMB 50 million, demonstrating the potential of data elementization in healthcare. The firm assigned a “Buy” rating with a target price of HKD 150.15. Kaiyuan Securities also forecasted in a December 2025 report that the company’s revenue will return to growth and may turn profitable in 2026.
Aligning with Industry Trends and Seizing the “AI + Healthcare” Gold Track
Healthy 160’s accelerated expansion comes at an opportune time. Currently, China’s smart hospital construction is shifting from “informatization” to “digital intelligence,” with hospitals facing multiple pressures to control costs, improve efficiency, and maintain quality, increasing demand for AI and other intelligent solutions. Meanwhile, national policies continuously promote “AI+” initiatives and “Internet + Healthcare,” creating a favorable policy environment for industry development.
Frost & Sullivan projects that by 2030, the market size of China’s digital healthcare comprehensive service industry will reach RMB 740.1 billion, with a compound annual growth rate of 22.4% from 2024 to 2030. Healthy 160’s deep deployment through the “160 AI Hospitals” initiative positions it to capitalize on this high-growth track.
Overall, the rapid increase in “160 AI Hospitals” partnerships in 2025, especially the concentrated implementation in the fourth quarter, sends a clear positive signal to the market. This not only demonstrates the market acceptance of its AI solutions but also injects strong momentum into future performance growth. As the value of AI-enabled healthcare gradually unfolds, Healthy 160 is expected to leverage its robust ecosystem barriers and first-mover advantages to realize a revaluation amid the wave of digital healthcare development.
(Author: Wang Zhiqiang HF013)